Why Flexion Therapeutics Is Tumbling 10% Today
The company priced a share offering, diluting existing shareholders.
FLEXION THERAPEUTI
The company priced a share offering, diluting existing shareholders.
FLXN earnings call for the period ending March 31, 2020.
FLXN earnings call for the period ending December 31, 2019.
A key FDA decision could pave the way for higher sales of the company's flagship drug.
FLXN earnings call for the period ending September 30, 2019.
For a few companies, the second half of 2019 will probably work out better than investors dared hope for earlier this year.
FLXN earnings call for the period ending June 30, 2019.
Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
FLXN earnings call for the period ending March 31, 2019.
The pharma company announced first-quarter 2019 operating results.